Cancer Institute A national cancer institute
designated cancer center

Sunita Pal

Publication Details

  • Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression.

    Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S, Jackman RJ, Jeffrey SS. Radiology. 2008; 246 (2): 367-75

    To prospectively determine if estrogen receptor (ER)-negative human epidermal growth factor receptor type 2 (HER2)-positive and ER-negative HER2-negative breast cancers have distinguishing clinical and imaging features with use of retrospectively identified patients and tissue samples.

    PubMedID: 18180338

Stanford Medicine Resources:

Footer Links: